Dopaminergic Pathway Genes Influence Adverse Events Related to Dopaminergic Treatment in Parkinson's Disease

類似資料

• Genetic variability of inflammation and oxidative stress genes does not play a major role in the occurrence of adverse events of dopaminergic treatment in Parkinson’s disease
  著者:: Redenšek, Sara, 等
  出版事項: (2019)
• Genetic Variability of the Vitamin D Receptor Affects Susceptibility to Parkinson’s Disease and Dopaminergic Treatment Adverse Events
  著者:: Sara Redenšek, 等
  出版事項: (2022-04-01)
• Clinical and Clinical-Pharmacogenetic Models for Prediction of the Most Common Psychiatric Complications Due to Dopaminergic Treatment in Parkinson’s Disease
  著者:: Redenšek, Sara, 等
  出版事項: (2020)
• Sensory Trick in Levodopa‐induced Orolingual Dystonia in a Patient with Advanced Parkinson's Disease
  著者:: Georgiev, Dejan, 等
  出版事項: (2016)
• Genetic Determinants of Parkinson's Disease: Can They Help to Stratify the Patients Based on the Underlying Molecular Defect?
  著者:: Redenšek, Sara, 等
  出版事項: (2017)